GIP has been described as a cell surface membrane perturbation agent, capable of disrupting tumor cell adhesion, membrane pseudopodial extensions, cell shape, aggregation, and cell agglutinating activities [19,23,24]. The gene discussed is GIP; the disease is neoplasm.